H

Hautarztpraxis Dr. med. Matthias Hoffmann | Witten, Germany

Research site
(Unclaimed)
Location
Annenstr 151, Witten, North Rhine-Westphalia, Germany
Site insights

Top conditions

Psoriasis (3 trials)

Atopic Dermatitis (2 trials)

Eczema (2 trials)

Dermatitis (2 trials)

Prurigo (1 trial)

Top treatments

Upadacitinib
HRO350
Ruxolitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) (TRuE-PN1)

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Enrolling
Prurigo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

HRO350 contains an oil-based extract from herring roe (Clupea harengus) in soft capsules and contains phospholipids (complex lipids) which are natura...

Active, not recruiting
Psoriasis
Drug: Placebo
Drug: HRO350

Trial sponsors

AbbVie logo

AbbVie (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems